[{"address1": "180 North LaSalle Street", "address2": "Suite 1600", "city": "Chicago", "state": "IL", "zip": "60601", "country": "United States", "phone": "844 445 5704", "website": "https://www.xerispharma.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Xeris Biopharma Holdings, Inc., a biopharmaceutical company, engages in developing and commercializing therapies in Illinois. The company offers Gvoke, a ready-to-use liquid-stable glucagon for the treatment of severe hypoglycemia pediatric and adult patients; Keveyis, a therapy for the treatment of hyperkalemic, hypokalemic, and related variants of primary periodic paralysis; and Recorlev, a cortisol synthesis inhibitor proved for the treatment of endogenous hypercortisolemia in adult patients with Cushing's syndrome. It is also developing XP-8121, a once-weekly subcutaneous injection of levothyroxine that is in phase I clinical trial for the treatment of hypothyroidism; and non-aqueous XeriSol and XeriJect technologies for various therapies. The company was incorporated in 2005 and is headquartered in Chicago, Illinois.", "fullTimeEmployees": 377, "companyOfficers": [{"maxAge": 1, "name": "Mr. John P. Shannon", "age": 62, "title": "CEO & Director", "yearBorn": 1962, "fiscalYear": 2023, "totalPay": 918153, "exercisedValue": 0, "unexercisedValue": 148377}, {"maxAge": 1, "name": "Mr. Steven M. Pieper", "age": 47, "title": "Chief Financial Officer", "yearBorn": 1977, "fiscalYear": 2023, "totalPay": 681142, "exercisedValue": 0, "unexercisedValue": 15586}, {"maxAge": 1, "name": "Ms. Beth P. Hecht J.D.", "age": 60, "title": "Chief Legal Officer & Corporate Secretary", "yearBorn": 1964, "fiscalYear": 2023, "totalPay": 695443, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Paul R. Edick J.D.", "age": 68, "title": "Senior Advisor", "yearBorn": 1956, "fiscalYear": 2023, "totalPay": 1206766, "exercisedValue": 0, "unexercisedValue": 590310}, {"maxAge": 1, "name": "Dr. Kenneth E. Johnson Pharm. D., Pharm.D.", "age": 61, "title": "Senior VP of Global Development & Medical Affairs", "yearBorn": 1963, "fiscalYear": 2023, "totalPay": 596967, "exercisedValue": 0, "unexercisedValue": 31173}, {"maxAge": 1, "name": "Ms. Allison  Wey", "title": "Senior Vice President of Investor Relations & Corporate Communications", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Brian  Conner", "title": "SVP of Quality and Chief Compliance & Risk Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Kendal  Korte", "title": "Senior Vice President of Human Resources", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Kevin  McCulloch", "title": "Chief Commercial Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 7, "boardRisk": 7, "compensationRisk": 7, "shareHolderRightsRisk": 8, "overallRisk": 7, "governanceEpochDate": 1738368000, "compensationAsOfEpochDate": 1703980800, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 3.76, "open": 3.74, "dayLow": 3.7, "dayHigh": 3.855, "regularMarketPreviousClose": 3.76, "regularMarketOpen": 3.74, "regularMarketDayLow": 3.7, "regularMarketDayHigh": 3.855, "payoutRatio": 0.0, "beta": 1.226, "forwardPE": -17.40909, "volume": 877468, "regularMarketVolume": 848841, "averageVolume": 1662825, "averageVolume10days": 2208610, "averageDailyVolume10Day": 2208610, "bid": 3.81, "ask": 3.86, "bidSize": 37, "askSize": 29, "marketCap": 570980160, "fiftyTwoWeekLow": 1.69, "fiftyTwoWeekHigh": 4.1, "priceToSalesTrailing12Months": 3.0474868, "fiftyDayAverage": 3.5102, "twoHundredDayAverage": 2.88665, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 772545024, "profitMargins": -0.33685002, "floatShares": 141766034, "sharesOutstanding": 149080992, "sharesShort": 10265230, "sharesShortPriorMonth": 10361048, "sharesShortPreviousMonthDate": 1736899200, "dateShortInterest": 1739491200, "sharesPercentSharesOut": 0.0689, "heldPercentInsiders": 0.03929, "heldPercentInstitutions": 0.44926998, "shortRatio": 7.27, "shortPercentOfFloat": 0.0706, "impliedSharesOutstanding": 149080992, "bookValue": -0.19, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1727654400, "netIncomeToCommon": -63113000, "trailingEps": -0.43, "forwardEps": -0.22, "enterpriseToRevenue": 4.123, "enterpriseToEbitda": -23.366, "52WeekChange": 0.23684216, "SandP52WeekChange": 0.14239466, "quoteType": "EQUITY", "currentPrice": 3.83, "targetHighPrice": 6.6, "targetLowPrice": 3.0, "targetMeanPrice": 5.1, "targetMedianPrice": 5.0, "recommendationKey": "none", "numberOfAnalystOpinions": 6, "totalCash": 69402000, "totalCashPerShare": 0.466, "ebitda": -33063000, "totalDebt": 270964992, "quickRatio": 1.215, "currentRatio": 1.789, "totalRevenue": 187360992, "revenuePerShare": 1.301, "returnOnAssets": -0.08701, "grossProfits": 152436992, "freeCashflow": -30717750, "operatingCashflow": -31485000, "revenueGrowth": 0.123, "grossMargins": 0.8136, "ebitdaMargins": -0.17647, "operatingMargins": -0.23758, "financialCurrency": "USD", "symbol": "XERS", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "messageBoardId": "finmb_105901792", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "esgPopulated": false, "regularMarketChangePercent": 1.8617004, "regularMarketPrice": 3.83, "corporateActions": [], "postMarketTime": 1740789489, "regularMarketTime": 1740776400, "exchange": "NMS", "market": "us_market", "marketState": "CLOSED", "shortName": "Xeris Biopharma Holdings, Inc.", "longName": "Xeris Biopharma Holdings, Inc.", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1529587800000, "postMarketChangePercent": 0.0, "postMarketPrice": 3.83, "postMarketChange": 0.0, "regularMarketChange": 0.06999993, "regularMarketDayRange": "3.7 - 3.855", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 1662825, "fiftyTwoWeekLowChange": 2.1399999, "fiftyTwoWeekLowChangePercent": 1.2662721, "fiftyTwoWeekRange": "1.69 - 4.1", "fiftyTwoWeekHighChange": -0.26999998, "fiftyTwoWeekHighChangePercent": -0.065853655, "fiftyTwoWeekChangePercent": 23.684216, "earningsTimestamp": 1741267800, "earningsTimestampStart": 1741267800, "earningsTimestampEnd": 1741267800, "earningsCallTimestampStart": 1741267800, "earningsCallTimestampEnd": 1741267800, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": -0.43, "epsForward": -0.22, "epsCurrentYear": -0.245, "priceEpsCurrentYear": -15.632652, "fiftyDayAverageChange": 0.3197999, "fiftyDayAverageChangePercent": 0.09110589, "twoHundredDayAverageChange": 0.94334984, "twoHundredDayAverageChangePercent": 0.32679743, "priceToBook": -20.157894, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "prevName": "Xeris Pharmaceuticals, Inc.", "nameChangeDate": "2025-02-28", "cryptoTradeable": false, "displayName": "Xeris Biopharma", "trailingPegRatio": null, "__fetch_time": "2025-03-01"}]